Purchase Order 75N93020P00666

This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...

This is a delivery order (HT942525F0013) awarded to Leinco Technologies, Inc., a self-certified small disadvantaged business and manufacturer of goods, by the Defense Health Agency (DHA) on October 31, 2024. The $33,125.00 firm fixed-price contract is for the provision of monoclonal antibodies derived from in-vivo genetically immunized knockout mice expressing the interferon-alpha/beta receptor alpha chain protein. This contract supports the agency's research and development efforts related to...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $740,000 firm fixed price delivery order contract to The Jackson Laboratory. Under the contract, Jackson Laboratory will provide COVID-19 novel mouse models, including ten mouse model test cohorts of 50 genetically engineered and validated mice per cohort and three colonies of approximately 1,000 mice each of a validated novel COVID-19 mouse model. The purpose is to support research efforts into...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.6 million delivery order to Colorado State University Sponsored Programs Division, doing business as Sponsored Programs, to establish small animal models for screening monoclonal antibodies and other countermeasures against SARS-CoV-2, the virus that causes COVID-19. This delivery order was issued against the NIAID's Preclinical Models of Infectious Diseases 2017-2024...

Genscript USA Inc. was awarded a $172,800 firm fixed price blanket purchase agreement call contract by the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services to provide SARS-COV-2 surrogate virus neutralization testing. The testing will support Wildlife Services' research and development efforts through June 2023. No set-aside provisions were applied to this contract awarded under the agency's SARS-COV-2 surrogate virus neutralization test blanket purchase...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Bio X Cell, LLC, a for-profit limited liability company. The $3,770.00 firm fixed price purchase order is for the provision of BIO X CELL RAT IGG1 ISOTYPE CONTROL HRPN and M IFN GAMMA XMG1.2 MG antibodies, which support COVID-19 research as well as research on vaccines and infectious diseases. Bio X Cell has previously provided...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $105,054.52 firm fixed-price purchase order to Tosoh Bioscience LLC, a for-profit limited liability company manufacturer, for the delivery of TOYOPEARL AF-RPROTEIN A HC-650F, 5L, 45UM. This award is associated with the Coronavirus COVID-19 national interest action and has a completion date of December 31, 2021. The place of performance is Japan. No set-aside...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $78,507.00 firm-fixed-price contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for Genscript Monoclonal Antibodies and Plasmid Services. This sole-source contract supports NIAID's Laboratory of Immunogenetics (LIG), which is expanding its work on isolating human monoclonal antibodies against COVID-19, malaria, and tuberculosis. The contract...

This federal contract award, valued at $3,869.87, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the procurement of mouse antibodies, which are likely to support various biomedical research and public health initiatives at NIAID and other agencies within the Department of Health and Human Services (HHS)....

This $5,373.75 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract is for the delivery of anti-mouse IgM reagents to support NIAID's research initiatives, which may include areas such as COVID-19, multiple sclerosis, and other...